Indication
Mediastinal Large B-cell Lymphoma
4 clinical trials
5 products
Clinical trial
A Phase 1b Multi-cohort Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic LeukemiaStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Product
TG-1801Product
UblituximabProduct
PembrolizumabClinical trial
A Phase II Study of Pembrolizumab (MK-3475) in Subjects With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) or Relapsed or Refractory Richter Syndrome (rrRS)Status: Completed, Estimated PCD: 2019-05-28
Clinical trial
Feasibility of Low Dose Radiation as Bridging Therapy for Lisocabtagene Maraleucel in Relapsed B-Cell Non-Hodgkin LymphomaStatus: Recruiting, Estimated PCD: 2025-07-01
Product
Liso-celClinical trial
A Phase I Study of T-cell Receptor Alpha Constant (TRAC) Locus Integrated CD19-Targeted 19(T2)28z1xx Chimeric Antigen Receptor (CAR) Modified T Cells in Adult Patients With CD19+ Relapsed or Refractory Large B-Cell LymphomaStatus: Recruiting, Estimated PCD: 2025-02-23
Product
19(T2)28z1xx TRAC T cell